Does Aggressive Therapy Improve Survival in Suboptimal Stage IIIc/IV Ovarian Cancer? A Canadian–American Comparative Study

By Lococo S.   Covens A.   Carney M.   Franssen E.   Dogde R.   Rosen B.   Osborne R.   Kerr I.   Buckman R.   Soper J.   Rodriguez G.   depetrillo A.   Clarke-Pearson D.   Berchuck A.  

Gynecologic Oncology, Vol. 59, Iss. 2, 1995-11 ,pp. : 194-199

Academic Press

Access to resources Recommend Favorite

Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Carcinoma: A Retrospective Analysis of 285 Patients

By Vergote I.   De Wever I.   Tjalma W.   Van Gramberen M.   Decloedt J.   van Dam P.  

Gynecologic Oncology, Vol. 71, Iss. 3, 1998-12 ,pp. : 431-436

Elsevier

Access to resources Recommend Favorite

Intravenous Chemotherapy, Early Debulking Surgery, and Consolidation Intraperitoneal Chemotherapy in Advanced Ovarian Carcinoma

By Tournigand C.   Louvet C.   Molitor J.-L.   Dehni N.   Lejeune V.   Sezeur A.   Pigne A.   Marpeau L.   Cady J.   de Gramont A.  

Gynecologic Oncology, Vol. 83, Iss. 2, 2001-11 ,pp. : 198-204

Elsevier

Access to resources Recommend Favorite

Progress in Survival Outcomes in Patients with Advanced Ovarian Cancer Treated by Neo-Adjuvant Platinum/Taxane-Based Chemotherapy and Late Interval Debulking Surgery

By Stoeckle Eberhard   Bourdarias Lionnel   Guyon Frédéric   Croce Sabrina   Brouste Véronique   Thomas Laurence   Floquet Anne  

Annals of Surgical Oncology, Vol. 21, Iss. 2, 2014-02 ,pp. : 629-636

Springer Publishing Company

Access to resources Recommend Favorite

Effect of Surgical Debulking on Survival in Stage IV Ovarian Cancer

By Liu P.C.   Benjamin I.   Morgan M.A.   King S.A.   Mikuta J.J.   Rubin S.C.  

Gynecologic Oncology, Vol. 64, Iss. 1, 1997-01 ,pp. : 4-8

Elsevier

Access to resources Recommend Favorite